Hilda Kennedy
Overview
Explore the profile of Hilda Kennedy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim B, Zheng Z, Lei J, Holt M, Chen A, Peng J, et al.
Cancer Res Commun
. 2023 Jul;
3(7):1366-1377.
PMID: 37501682
Significance: A major challenge for targeting the consequence of tumor suppressor disruption is the accurate assessment of protein functional inactivation. NF1 can repress both RAS and ER signaling, and a...
2.
Zheng Z, Elsarraj H, Lei J, Hong Y, Anurag M, Feng L, et al.
Breast Cancer Res
. 2022 Oct;
24(1):68.
PMID: 36258226
Background: Ductal carcinoma in situ (DCIS) is the most common type of in situ premalignant breast cancers. What drives DCIS to invasive breast cancer is unclear. Basal-like invasive breast cancers...
3.
Sun Y, Ye X, Kennedy H, Smith A, Smith R
J Transl Int Med
. 2022 Aug;
10(2):146-155.
PMID: 35959447
Background And Objectives: Activation of ghrelin receptor growth hormone secretagogue receptor (GHS-R) by endogenous or synthetic ligands amplifies pulsatile release of growth hormone (GH) and enhances food intake, very relevant...
4.
Zheng Z, Anurag M, Lei J, Cao J, Singh P, Peng J, et al.
Cancer Cell
. 2020 Mar;
37(3):387-402.e7.
PMID: 32142667
We report that neurofibromin, a tumor suppressor and Ras-GAP (GTPase-activating protein), is also an estrogen receptor-α (ER) transcriptional co-repressor through leucine/isoleucine-rich motifs that are functionally independent of GAP activity. GAP...